Artelo Biosciences Unveils $11.0 Mln Private Placement Of Shares And Warrants; Stock Down

Artelo Biosciences entered definitive agreements to sell 3.188 million shares and warrants to purchase up to 6.38 million additional shares. The financing provides near-term capital for the clinical-stage biotech but will be dilutive to existing shareholders; pricing and use of proceeds were not provided in the article. Monitor final terms and filings for impact on share count and runway.

Analysis

Artelo Biosciences entered definitive agreements to sell 3.188 million shares and warrants to purchase up to 6.38 million additional shares. The financing provides near-term capital for the clinical-stage biotech but will be dilutive to existing shareholders; pricing and use of proceeds were not provided in the article. Monitor final terms and filings for impact on share count and runway.